These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 5676640)

  • 1. Heparin cofactor deficiency and instability as reflected by the 24-hour heparin clot inhibition test.
    Koszewski BJ; Powell LW; Vahabzadeh H
    Vasc Dis; 1968 Sep; 5(3):152-64. PubMed ID: 5676640
    [No Abstract]   [Full Text] [Related]  

  • 2. [Heparin cofactor II studies in thrombophilic patients].
    Pál A; Sas G
    Orv Hetil; 1990 Mar; 131(9):461-2, 465. PubMed ID: 2179813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Role of newly developed technology in blood coagulation disorders].
    Matsuo T
    Rinsho Byori; 2002 May; 50(5):506-12. PubMed ID: 12078050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Studies on plasma hypercoagulability. 1. Heparin resistance in various diseases and its relation to coagulation factors, anticoagulant therapy, platelet and heparin co-factor].
    Satake K
    Naika Hokan; 1969 Apr; 16(4):127-38. PubMed ID: 5816626
    [No Abstract]   [Full Text] [Related]  

  • 5. New diagnostic possibilities for the detection of thrombophilic states.
    Vinazzer H
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(3):253-9. PubMed ID: 2465211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [New screening method for coagulation abnormality including AT III deficiency during CABG].
    Nakamura K; Hata T; Tsushima Y; Matsumoto M; Hamanaka S; Yoshitaka H; Morishita A; Shinoura S; Minami H; Ohtani S
    Kyobu Geka; 1999 Jul; 52(7):554-8. PubMed ID: 10402784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An antithrombin III assay based on factor Xa inhibition provides a more reliable test to identify congenital antithrombin III deficiency than an assay based on thrombin inhibition.
    Demers C; Henderson P; Blajchman MA; Wells MJ; Mitchell L; Johnston M; Ofosu FA; Fernandez-Rachubinski F; Andrew M; Hirsh J
    Thromb Haemost; 1993 Mar; 69(3):231-5. PubMed ID: 8470046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The progressive antithrombin (antithrombin-III, heparin-cofactor).
    Pálos LA
    Haematologia (Budap); 1974; 8(1-4):455-9. PubMed ID: 4461431
    [No Abstract]   [Full Text] [Related]  

  • 9. [Blood coagulation mechanism from the viewpoint of molecular biochemistry: Inhibition mechanism of blood coagulation--especially on the function of antithrombin III].
    Sakuragawa N
    Rinsho Byori; 1985 Sep; 33(9):974-81. PubMed ID: 3841167
    [No Abstract]   [Full Text] [Related]  

  • 10. Thrombin-based antithrombin assays show overestimation of antithrombin III activity in patients on heparin therapy due to heparin cofactor II influence.
    Bohner J; von Pape KW; Blaurock M
    Thromb Haemost; 1994 Mar; 71(3):280-3. PubMed ID: 8029789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prothrombin fragment 1 + 2, thrombin-antithrombin III-complexes and fibrinopeptide A in spontaneously clotting whole blood in vitro. Effects of heparin addition and antithrombin III deficiency.
    Herren T; Straub PW; Haeberli A
    Thromb Haemost; 1994 Jan; 71(1):49-53. PubMed ID: 8165646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antithrombin III (clinical aspects and methodology)].
    Abildgaard U
    Ric Clin Lab; 1978; 8 Suppl 2():90-7. PubMed ID: 106453
    [No Abstract]   [Full Text] [Related]  

  • 13. [Antithrombin III: critical review of the methods used for its monitoring in thrombophilic states].
    Modiano A; Belisario A
    G Clin Med; 1981 Sep; 62(9):597-608. PubMed ID: 7033027
    [No Abstract]   [Full Text] [Related]  

  • 14. Inhibition of thrombin by antithrombin III and heparin cofactor II in vivo.
    Liu L; Dewar L; Song Y; Kulczycky M; Blajchman MA; Fenton JW; Andrew M; Delorme M; Ginsberg J; Preissner KT
    Thromb Haemost; 1995 Mar; 73(3):405-12. PubMed ID: 7545318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Functional status of the hemostasis system in patients with arteriosclerotic lesions of the terminal segment of the aorta and iliac arteries].
    Tiutrin II; Udut VV; Ivchenko OV; Tsisik RM
    Vestn Khir Im I I Grek; 1988 Aug; 141(8):60-2. PubMed ID: 3232299
    [No Abstract]   [Full Text] [Related]  

  • 16. [Recommendations for initial diagnosis and therapy in acute blood coagulation disorders].
    Sütterlin R; Barthels D
    Anaesthesiol Reanim; 1996; 21(3):76-80. PubMed ID: 8766399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Significance of disordered antithrombin III function in disseminated intravascular coagulation and deep venous thrombosis for anticoagulant therapy].
    von Blohn G; Reiter B; Hellstern P; Wenzel E; Köhler M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(4):426-38. PubMed ID: 6083907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Heparin tolerance test in vitro. Its present position among hemostasis tests].
    Soulier JP
    Presse Med (1893); 1971 Jul; 79(35):1565-6. PubMed ID: 5568991
    [No Abstract]   [Full Text] [Related]  

  • 19. Anti-thrombin III levels in some Malaysian patients suspected of having acquired coagulation disorders.
    Tan SH; Doraisamy G; Noriah R; Lopez CG
    Singapore Med J; 1983 Feb; 24(1):33-6. PubMed ID: 6867763
    [No Abstract]   [Full Text] [Related]  

  • 20. Inherited antithrombin III deficiency and cerebral thrombosis in a child.
    Ambruso DR; Jacobson LJ; Hathaway WE
    Pediatrics; 1980 Jan; 65(1):125-31. PubMed ID: 7355006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.